YAKUGAKU ZASSHI
The Pharmaceutical Society of Japan, established in 1880, is one of Japan’s oldest and most distinguished academic societies. The Society currently has around 15,000 members. It publishes three monthly scientific journals. Chemical and Pharmaceutical Bulletin (Chem. Pharm. Bull.) began publication in 1953 as Pharmaceutical Bulletin. It covers chemistry fields in the pharmaceutical and health sciences. Biological and Pharmaceutical Bulletin (Biol. Pharm. Bull.) began publication in 1978 as the Journal of Pharmacobio-Dynamics, which then merged the Journal of Health Science, another former Society’s journal, in 2012. It covers various biological topics in the pharmaceutical and health sciences. Yakugaku Zasshi (Japanese for “Pharmaceutical Science Journal”) has the longest history, with publication beginning in 1881. Yakugaku Zasshi is published mostly in Japanese, except for some articles related to clinical pharmacy and pharmaceutical education, which are published in English. The main aim of the Society’s journals is to advance the pharmaceutical sciences with research reports, scientific communication, and high-quality discussion. The average review time for articles submitted to the journals is around one month for first decision. The complete texts of all of the Society’s journals can be freely accessed through J-STAGE. The Society’s editorial committee hopes that the content of its journals will be useful to your research, and also invites you to submit your own work to the journals.

Chairman of Committee
Hidehiko Nakagawa
Graduate School of Pharmaceutical Sciences, Nagoya City University
Read more
18,188 registered articles
(updated on December 03, 2025)
Online ISSN : 1347-5231
Print ISSN : 0031-6903
ISSN-L : 0031-6903
0.2
2024 Journal Impact Factor (JIF)
JOURNAL PEER REVIEWED FREE ACCESS FULL-TEXT HTML ADVANCE PUBLICATION
Scopus Pubmed
Featured article
Volume 145 (2025) Issue 12 Pages 967-973
Evaluation of the Safety of Lansoprazole Exposure During Early Pregnancy: A Prospective Cohort Study Using Two-Center Counseling Data in Japan Read more
Editor's pick

This study provides reassuring evidence on the safety of lansoprazole use during early pregnancy. Drawing on data from two Japanese hospitals over nearly three decades (1988–2017), the authors found no increased risk of major malformations among infants exposed to lansoprazole in the first trimester. These findings fill an important gap in Japan’s limited evidence on medication safety during pregnancy and support informed selection of proton pump inhibitors for pregnant women.

View all featured articles
Most viewed articles (November 2025)
Share this page
Browse by volume and issue
Announcements from publisher
feedback
Top